Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-18
Biography and Research Information
OverviewAI-generated summary
Luke Enemark's research focuses on the discovery of novel therapeutic compounds, specifically investigating 1H-pyrazolo[3,4-d]pyrimidine derivatives. His work centers on identifying inhibitors for BRK/PTK6, enzymes implicated in cellular signaling pathways. Enemark has co-authored publications with researchers Sayem Miah and Maha Hanafi at the University of Arkansas for Medical Sciences, indicating collaborative efforts within the institution. His recent publications in 2025 highlight his active engagement in exploring new chemical entities for potential medical applications. Enemark has a total of two publications, demonstrating a focused output in his research area.
Metrics
- Publications: 2
Selected Publications
-
Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors (2025)
-
Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors (2025)
Collaboration Network
Top Collaborators
Baku Acharya
University of Arkansas for Medical Sciences
2 shared publications
In database
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Maha Hanafi
University of Arkansas for Medical Sciences
2 shared publications
In database
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Debasmita Saha
Discovery Institute (US)
2 shared publications
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Sayem Miah
University of Arkansas for Medical Sciences
2 shared publications
In database
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Brendan Frett
University of Arkansas for Medical Sciences
2 shared publications
In database
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Daniel W. Armstrong
University of Arkansas for Medical Sciences
1 shared publication
In database
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Similar Researchers
Based on overlapping research topics
Ebony Cotton
National Center for Toxicological Research
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Receptor Mechanisms and Signaling
Dane Richey
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Medical Research
Lirit N. Franks
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Receptor Mechanisms and Signaling
Ponmari Guruvaiya
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Medical Research
Alev Tascioglu Aliyev
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Receptor Mechanisms and Signaling
Azure L. Yarbrough
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Receptor Mechanisms and Signaling